Executive Chairman Sells $22.2M in Hinge Health Stock Near 52-Week High
HNGE has more than doubled off its 52-week low of $30.08.
Summary
Executive Chairman Gabriel Mecklenburg sold $22.2M of Hinge Health stock near the 52-week high under a pre-planned 10b5-1 program, adding to a heavy insider distribution trend.
Key Events · Ownership and Investor Activity · HNGE
-
Executive Chairman Sells $22.2M
Gabriel Mecklenburg sold 250,000 Class A shares for $22,242,069 on September 11, 2026, at weighted average prices between $87.02 and $90.46.
-
10b5-1 Plan Execution
The sale was executed under a Rule 10b5-1 trading plan adopted June 12, 2026, indicating the transaction was pre-scheduled rather than a reaction to current market conditions.
-
Broader Insider Distribution
This sale adds to $265.7 million in net insider selling over the past 90 days with zero open-market purchases, alongside multiple large Form 144 filings from institutional holder Insight Venture Partners.
-
Post-Sale Ownership
Mecklenburg retains 1,944,004 Class B shares directly, plus 383,592 shares held by a family trust and 692,710 shares held by a GRAT, indicating continued significant economic exposure.
Analysis · HNGE · Technology
Gabriel Mecklenburg, Executive Chairman and Co-Founder, sold 250,000 Class A shares for $22.24 million on September 11, 2026, at prices between $86.35 and $90.61 — just below the stock's 52-week high of $95.57. The sale was executed under a pre-existing 10b5-1 trading plan adopted June 12, 2026, which reduces the signal of opportunistic timing. However, the transaction continues a broader distribution pattern: insiders have sold $265.7 million over the past 90 days with zero open-market purchases, and major institutional holder Insight Venture Partners has filed multiple Form 144s to sell over $200 million in stock. Mecklenburg retains 1,944,004 Class B shares directly plus additional holdings through trusts, so this is a partial monetization rather than an exit.
How filings like this one have moved
In the 30 days to Oct 31, 2026, 31.5% of the 1750 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HNGE was trading at $94.00 on NYSE in the Technology sector, with a market capitalization of approximately $7.6B. The 52-week trading range was $30.08 to $95.57. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.